Abstract
Atrazine, a widely used chlorotriazine herbicide, has been regulated and reviewed because of its ability to alter endocrine signaling and cause mammary tumors in female Sprague–Dawley rats. The ability of atrazine to cause breast cancer in humans has been studied and the results are equivocal. Rodent studies showed that atrazine alters the developing mammary gland, makes it susceptible to tumorigenesis or hyperplasia, alters lactational ability, and decreases weight gain in second-generation litters. This chapter reviews the proposed mode of action for mammary tumorigenesis in rodents, results of human studies, and potential modes of action for atrazine effects on the developing mammary gland.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ansell C (2008) Pesticide regulation in the EU and California. Institute of Governmental Studies, UC Berkeley. http://escholarship.org/uc/item/7h47100p. Accessed 20 June 2010
Ashby J, Tinwell H, Stevens J, Pastoor T, Breckenridge CB (2002) The effects of atrazine on the sexual maturation of female rats. Reg Toxicol Pharmacol 35:468–473
ATSDR Agency for Toxic Substances and Disease Registry (2003) Toxicological profile for atrazine. U.S. Department of Health and Human Services, Public Health Service, Atlanta, Georgia
Atwood CS, Hovey RC, Glover JP, Chepko G, Ginsburg E, Robison WG, Vonderhaar BK (2000) Progesterone induces side-branching of the ductal epithelium in the mammary gland of peripubertal mice. J Endrocrinol 167:39–52
Baker DB (1998) Herbicides in drinking water: a challenge for risk communication. In: Ballantine LG, McFarland JE, Hackett DS (eds) Triazine herbicides risk assessment. American Chemical Society, Washington
Barr DB, Panuwet P, Nguyen JV, Udunka S, Needham LL (2007) Assessing exposure to atrazine and its metabolites using biomonitoring. Environ Health Perspect 115:1474–1478
Borellini F, Oka T (1989) Growth control and differentiation in mammary epithelial cells. Environ Health Perspect 80:85–89
Cooper RL, Stoker TE, Goldman JM, Parrish MB, Tyrey L (1996) Effect of atrazine on ovarian function in the rat. Reprod Toxicol 10:257–263
Cooper RL, Stoker TE, Tyrey L, Goldman JM, McElroy WK (2000) Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci 53:297–307
Cooper RL, Laws SC, Das PC, Narotsky MG, Goldman JM, Tyrey EL, Stoker TE (2007) Atrazine and reproductive function: mode and mechanism of action studies. Birth Defects Res B 80:98–112
Daniel CW, Silberstein GB (1987) Postnatal development of the rodent mammary gland. In: Neville M, Daniel C (eds) The mammary gland. Plenum Press, New York
Deb G (2006) Atrazine: a case study in the differences between regulations of endocrine disrupting chemicals in the EU and the US. Temple J Sci Tech Environ Law 25:173–190
Eldridge JC, Wetzel LT, Tyrey L (1999a) Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration. Reprod Toxicol 13:491–499
Eldridge JC, Wetzel LT, Stevens JT, Simpkins JW (1999b) The mammary tumor response in triazine-treated female rats: a threshold-mediated interaction with strain and species-specific reproductive senescence. Steroids 64:672–678
Enoch RR, Stanko JP, Greiner SN, Youngblood GL, Rayner JL, Fenton SE (2007) Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats. Environ Health Perspect 115:541–547
EU European Union (2004) Commission decision of 10 March 2004 concerning the non-inclusion of atrazine in Annex I to Council Directive 91/414/EED and the withdrawal of authorizations for plant protection products containing this active substance (text with EEA relevance) (notified under document number C(2004)731). http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!prod!CELEXnumdoc&lg=EN&numdoc=32004D0248&model=guichett. Accessed 27 June 2010
Fenton SE (2006) Endocrine-disrupting compounds and mammary gland development: early exposures and later life consequences. Endocrinology 147S:S18–S24
Fraites MJ, Cooper RL, Buckalew A, Jayaraman S, Mills L, Laws SC (2009) Characterization of the hypothalamic-pituitary-adrenal axis response to atrazine and metabolites in the female rat. Toxicol Sci 112:88–99
Fukamachi K, Han BS, Kim CK, Takasuka N, Matsuoka Y, Matsuda E, Yamasaki T, Tsuda H (2004) Possible enhancing effects of atrazine and nonylphenol on 7,12-dimethylbenz[a]-anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Cancer Sci 95:404–410
Gammon DW, Aldous CN, Carr WC Jr, Sanborn JR, Pfiefer KF (2005) A risk assessment of atrazine use in California: human health and ecological aspects. Pest Manag Sci 61:331–355
Gianessi LP (1998) Benefits of triazine herbicides. In: Ballantine LG, McFarland JE, Hackett DS (eds) Triazine herbicides risk assessment. American Chemical Society, Washington
Hopenhayn-Rich C, ML Stump, Browning SR (2002) Regional assessment of atrazine exposure and incidence of breast and ovarian cancers in Kentucky. Arch Environ Contam Toxicol 42:127–136
Hovey RC, Trott JF, Vonderhaar BK (2002) Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 7:17–38
Imagawa W, Bandyopadhyay GK, Nandi S (1990) Regulation of mammary epithelial cell growth in mice and rats. Endocr Rev 11:494–523
Imagawa W, Yang J, Guzman R, Nandi S (1994) Control of mammary gland development. In: Knobin E, Neill JD (eds) The physiology of reproduction, 2nd edn. Raven Press, New York
Kaplowitz PB (2010) Precocious puberty. http://emedicine.medscape.com/article/924002-overview. eMedicine. 29 March 2010. Accessed 8 July 2010
Kettles MA, Browning SR, Prince TS, Horstman SW (1997) Triazine herbicide exposure and breast cancer incidence: an ecologic study of Kentucky counties. Environ Health Perspect 105:1222–1227
Kleinberg DL, Feldman M, Ruan W (2000) IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5:7–17
Knudson AG (1996) Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 122:135–140
Laws SC, Ferrell JM, Stoker TE, Schmid J, Cooper RL (2000) The effects of atrazine on female Wistar rats: an evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol Sci 58:366–376
Laws SC, Ferrell JM, Stoker TE, Cooper RL (2003) Pubertal development in female Wistar rats following exposure to propazine and atrazine biotransformation by-products, diamino-s-chlorotriazine and hydroxyatrazine. Toxicol Sci 76:190–200
Masso-Welch PA, Darcey KM, Stangle-Castor NC, Ip MM (2000) A developmental atlas of rat mammary gland histology. J Mammary Gland Biol Neoplasia 5:165–185
McElroy JA, Gangnon RE, Newcomb PA, Kanarek MS, Anderson HA, Brook JV, Trentham-Dietz A, Remington PL (2007) Risk of breast cancer for women living in rural areas from adult exposure to atrazine from well water in Wisconsin. J Expo Sci Environ Epidemiol 17:207–214
McManaman JL, Neville MC (2003) Mammary physiology and milk secretion. Adv Drug Deliv Rev 55:629–641
Moon HJ, Han SY, Shin J-H, Kang IH, Kim TS, Hong JH, Kim S-H, Fenton SE (2007) Gestational exposure to nonylphenol causes precious mammary gland development in female rat offspring. J Reprod Dev 53:333–344
Morgenstern H (1995) Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 16:61–81
Muir K, Rattanamongkolgul S, Smallman-Raynor M, Thomas M, Downer S, Jenkinson C (2004) Breast cancer incidence and its possible spatial association with pesticide application in two counties of England. Public Health 118:512–520
Naylor MJ, Lockefeer JA, Horseman ND, Ormandy CJ (2003) Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism. Endocrine 20:111–114
Norrgran J, Bravo R, Bishop AM, Restrepo P, Whitehead RD, Needham LL, Barr DB (2006) Quantification of six herbicide metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci 18:185–195
Rayner JL, Wood C, Fenton SE (2004) Exposure parameters necessary for delayed puberty and mammary gland development in Long-Evans rats exposed in utero to atrazine. Toxicol Appl Pharmacol 195:23–34
Rayner JL, Enoch RR, Fenton SE (2005) Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci 81:255–266
Rusiecki JA, de Roos A, Lee WJ, Dosemeci M, Lubin JH, Hoppin JA, Blair A, Alavanja MCR (2004) Cancer incidence among pesticide applicators exposed to atrazine in the agricultural health study. J Natl Cancer Inst 96:1375–1382
Russo I, Russo J (1978) Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 61:1439–1449
Sakakura T (1987) Mammary embryogenesis. In: Neville M, Daniel C (eds) The mammary gland. Plenum Press, New York
Silberstein GB (2001) Postnatal mammary gland morphogenesis. Microsc Res Tech 52:155–162
Simpkins JW, Eldridge JC, Wetzel LT (1998) Role of strain-specific reproductive patterns in the appearance of mammary tumors in atrazine-treated rats. In: Ballantine LG, McFarland JE, Hackett DS (eds) Triazine herbicides risk assessment. American Chemical Society, Washington
Stoker TE, Cooper TL (2007) Distribution of 14C-atrazine following an acute lactational exposure in Wistar rats. Reprod Toxicol 23:607–610
Stoker TS, Guidici DL, Laws SC, Cooper RL (2002) The effects of atrazine metabolites on puberty and thyroid function in the male Wistar rat. Toxicol Sci 67:198–206
Thomas MG, Thomas JA (2001) Toxic responses of the reproductive system. In: Klaassen CJ (ed) Casarett and Doull’s toxicology the basic science of poisons, 6th edn. McGraw-Hill, New York
Topper YJ, Freeman CS (1980) Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60:1049–2000
Ueda M, Imai T, Takizawa T, Onodera H, Mitsumori K, Matsui T, Hirose M (2005) Possible enhancing effects of atrazine on growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in ovariectomized Sprague-Dawley rats. Cancer Sci 96:19–25
US EPA United States Environmental Protection Agency (2002) Overview of atrazine risk assessment. 2 May 2002. Office of Prevention, Pesticides, and Toxic Substances. EPA Docket EPA-HQ-OPP-2007-0151
US EPA United States Environmental Protection Agency (2003) Revised atrazine interim reregistration eligibility decision. Oct 2003. Office of Prevention, Pesticides, and Toxic Substances. EPA Docket EPA-HQ-OPP-2007-0151
US EPA United States Environmental Protection Agency (2004) Memorandum errata/addendum sheet for changes to the atrazine interim reregistration eligibility decision. Jan 2003. Amended March 2004. Office of Prevention, Pesticides, and Toxic Substances. http://www.epa.gov/oppsrrd1/REDs/atrazine_ired.pdf. Accessed 15 June 2010
US EPA United States Environmental Protection Agency (2006) Triazine cumulative risk assessment. 28 March 2006. http://www.epa.gov/oppsrrd1/REDs/triazine_cumulative_risk.pdf. Accessed 15 June 2010
US EPA United States Environmental Protection Agency (2010) Atrazine updates. http://www.epa.gov/opp00001/reregistration/atrazine/atrazine_update.htm. Accessed 27 June 2010
USGS United States Geological Survey (2006) The quality of our nation’s waters: pesticides in the nation’s streams and groundwater, 1992–2001. Revised 15 Feb 2007. US Geological Circular 1291. Reston Virginia. http://pubs.usgs.gov/circ/2005/1291/pdf/circ1291.pdf. Accessed 15 June 2010
USGS United States Geological Survey (2009a) Watershed regressions for pesticides (WARP) atrazine model. http://infotrek.er.usgs.gov/warp. Accessed 15 June 2010
USGS United States Geological Survey (2009b) Trends in pesticide concentrations in Corn-Belt streams, 1996–2006. Scientific Investigations report 2009-5132. http://pubs.usgs.gov/sir/2009/5132/pdf/sir20095132.pdf. Accessed 15 June 2010
Vecchia AV, Gilliom RJ, Sullivan DJ, Lorenz DJ, Martin JD (2009) Trends in concentrations and use of agricultural herbicides for Corn Belt rivers, 1996–2006. Environ Sci Technol 43:9096–9102
Wetzel LT, Luempert LC III, Breckenridge CB, Tisdel MO, Stevens JT, Thakur AK, Extrom PJ, Eldridge JC (1994) Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague–Dawley and Fischer 344 rats. J Toxicol Environ Health 43:182–196
Wu J, Robinson RA, Simoneaux B (1998) Metabolism of selected (s)-triazines in animals. In: Ballantine LG, McFarland JE, Hackett DS (eds) Triazine herbicides risk assessment. American Chemical Society, Washington
You L, Gazi E, Archibeque-Engle S, Casanova M, Conolly RB, Heck HA (1999) Transplacental and lactational transfer of p, p′-DDE in Sprague–Dawley rats. Toxicol Appl Pharmacol 157:134–144
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rayner, J.L., Fenton, S.E. (2011). Atrazine: An Environmental Endocrine Disruptor That Alters Mammary Gland Development and Tumor Susceptibility. In: Russo, J. (eds) Environment and Breast Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9896-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9896-5_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-9895-8
Online ISBN: 978-1-4419-9896-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)